|
|
|
Volumn 12, Issue 1, 1996, Pages 89-92
|
|
Interpreting results from thrombolytic megatrials: Distinguishing fact from fiction
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOLYTIC AGENT;
ACUTE HEART INFARCTION;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG CHOICE;
FIBRINOLYTIC THERAPY;
HUMAN;
META ANALYSIS;
METHODOLOGY;
SHORT SURVEY;
COST-BENEFIT ANALYSIS;
DATA INTERPRETATION, STATISTICAL;
FIBRINOLYTIC AGENTS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
|
|
EID: 0030019656
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
